Vivos Inc (OP: RDGL )

0.1825 -0.0100 (-5.19%)
Streaming Delayed Price Updated: 3:41 PM EDT, Jul 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 766,415
Open 0.1990
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.1925
Today's Range 0.1765 - 0.1990
52wk Range 0.0412 - 0.2550
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Vivos One Step Closer To Transforming Cancer Treatment With FDA Application To Start Human Trials For Pioneering Injectable Brachytherapy Device
Vivos One Step Closer To Transforming Cancer Treatment With FDA Application To Start Human Trials For Pioneering Injectable Brachytherapy Device 
Via News Direct
Exposures Product Safety
Alset And 2 Other Stocks Under $2 Insiders Are Buying
Via Benzinga

Performance

YTD
+140.13%
+140.13%
1 Month
+6.48%
+6.48%
3 Month
+124.75%
+124.75%
6 Month
+154.18%
+154.18%
1 Year
+246.30%
+246.30%

More News

Read More
3 Stocks to Turn $1,000 Into $1 Million: February 2024
Via InvestorPlace
High-Risk, High-Reward: 7 OTC Stocks That Could Make You Rich This Year
Via InvestorPlace
New Hope In Cancer Battle: FDA Grants Breakthrough Device Status To Vivos Inc.'s RadioGel
Via Benzinga
Exposures Product Safety
Radiogel Precision Radionuclide Therapy Receives FDA Breakthrough Device Designation
Via NewMediaWire
Exposures Product Safety
Gossamer Bio And 2 Other Stocks Under $1 Insiders Are Buying
Via Benzinga
Topics Stocks
Exposures US Equities
Black Diamond Therapeutics And 2 Other Stocks Under $3 Insiders Are Buying
Via Benzinga
Topics Stocks
Exposures US Equities
Great Elm Group And 3 Other Stocks Under $5 Insiders Are Aggressively Buying
Via Benzinga
Insiders Buying These 4 Penny Stocks
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.